Weiss Multi-Strategy Advisers LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$4,498,000
+181.5%
66,052
+32.1%
0.12%
+147.9%
Q2 2022$1,598,000
+476.9%
50,000
+525.0%
0.05%
+700.0%
Q1 2022$277,000
-62.8%
8,000
-68.5%
0.01%
-64.7%
Q4 2021$744,000
+14.5%
25,414
-0.4%
0.02%
+21.4%
Q3 2021$650,000
-15.6%
25,518
+16.0%
0.01%
-17.6%
Q2 2021$770,000
+17.6%
22,000
+36.9%
0.02%
+21.4%
Q1 2021$655,000
-30.2%
16,073
-25.8%
0.01%
-22.2%
Q4 2020$938,000
-46.8%
21,666
-32.3%
0.02%
-61.7%
Q3 2020$1,764,000
+3.0%
32,000
+17.9%
0.05%
-4.1%
Q2 2020$1,713,000
+26.9%
27,134
+2.7%
0.05%
-7.5%
Q1 2020$1,350,000
+13.3%
26,416
+76.1%
0.05%
+178.9%
Q4 2019$1,192,000
+63.7%
15,0000.0%0.02%
+26.7%
Q3 2019$728,000
-7.7%
15,0000.0%0.02%
-28.6%
Q2 2019$789,000
+74.6%
15,000
+50.0%
0.02%
+90.9%
Q2 2018$452,000
-50.1%
10,000
-46.7%
0.01%
-62.1%
Q1 2018$906,000
+129.9%
18,750
+87.5%
0.03%
+190.0%
Q4 2017$394,00010,0000.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders